Insider · CIK 0001164475
Ronald J Daniels
Files at BBIO (BridgeBio Pharma, Inc.). First filing Nov 7, 2025, latest Nov 7, 2025.
Ronald J Daniels files SEC Form 4 as director at BBIO (BridgeBio Pharma, Inc.). Since Nov 7, 2025, Ronald J Daniels has reported 0 open-market buys worth $0 and 1 open-market sell worth $3.9M, the latest filed on Nov 7, 2025.
A track record needs three past buys with six months of prices behind them; Ronald J Daniels has 0, so none is measured yet.
The newest scored trade: sold $3.9M of BBIO on Nov 6, 2025, filed Nov 7, 2025, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $3.9M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | BridgeBio Pharma, Inc. | $3.9M 61,031 shares | -78% | +181% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 6, 2025 | BBIO BRIDGEBIO PHARMA, INC. | 61,031 0.03% of outstanding | $3.9M | Nov 6, 2025 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +3,990 | $0.00 | $0 | 20,981 | Jun 24, 2026 |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,277 | $0.00 | $0 | 5,277 | Jun 24, 2026 |
| Nov 6, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock | +61,031 | $34.65 | $2.1M | 78,022 | Nov 7, 2025 |
| Nov 6, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -61,031 | $63.72 | $3.9M | 16,991 | Nov 7, 2025 |
| Nov 6, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -61,031 | $0.00 | $0 | 30,523 | Nov 7, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 16,991 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
Questions about Ronald J Daniels
Answered from the filings on this page, as of the latest one.
Is Ronald J Daniels buying or selling?
In the last 12 months Ronald J Daniels reported 0 open-market buys worth $0 and 1 open-market sell worth $3.9M on SEC Form 4; the latest was sold $3.9M of BBIO on Nov 6, 2025. Grants, option exercises and tax withholding are not counted.
How did Ronald J Daniels's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald J Daniels has 0.
Where does Ronald J Daniels file Form 4?
Ronald J Daniels has filed Form 4 at BBIO (BridgeBio Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.